Penumbra, Inc. Reports First Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports First Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 44.98 -2.82 (5.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.80 | 52 Week High | $24.79 | |||
| Open | $47.43 | 52 Week Low | $15.67 | |||
| Day High | $47.45 | P/E | N/A | |||
| Day Low | $44.85 | EPS | $-0.09 | |||
| Volume | 29,026,349 | |||||
| (NYSE: PEN) | Delayed: 319.26 -2.91 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.17 | 52 Week High | $79.49 | |||
| Open | $322.61 | 52 Week Low | $40.23 | |||
| Day High | $322.61 | P/E | N/A | |||
| Day Low | $319.18 | EPS | $0.00 | |||
| Volume | 380,770 | |||||
